🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effectiveness of OLE Airway Clearance Therapy in ICU Patients With Pulmonary Infections

RecruitingNAAges 18 Years - anyAllChinese PLA General Hospital
NCT07395297 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to explore the application of Electrical Impedance Tomography (EIT) in evaluating the effectiveness of OLE (Oscillatory Lung Expansion) airway clearance therapy for ICU patients with pulmonary infections. The goal is to understand the treatment response differences in patients with various causes of atelectasis (lung collapse). The study will include adult patients diagnosed with pulmonary infections and admitted to the ICU. The primary endpoint of the study is the peak cough flow (CPF), which measures the patient's ability to clear secretions from the lungs through coughing.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: 1. Clearly diagnosed with pulmonary infection in the ICU, confirmed by microbiological tests (sputum culture, blood culture, etc.) or imaging tests (chest CT, chest X-ray); 2. Age ≥ 18 years; 3. Respiratory support is oxygen therapy (nasal cannula or face mask oxygen therapy); 4. Sputum volume \> 30 ml/day; 5. The patient or their legal representative signs the informed consent form. Exclusion Criteria: 1. Pregnant or breastfeeding women; 2. Presence of respiratory or circulatory failure (requiring mechanical ventilation or vasopressor support to maintain circulation); 3. Untreated tension pneumothorax; 4. Body Mass Index (BMI) exceeding 50 kg/m²; 5. Rib deformities or severe thoracic deformities; 6. Contraindications for the use of EIT (such as implanted automatic cardiac defibrillators, acute chest trauma, subcutaneous implanted pumps, etc.); 7. Early withdrawal from the study or incomplete clinical data.
💊

What it tests

  • Oscillatory Lung Expansion (OLE) Therapy
📍

Where

1 site
Chinese PLA Hospital
Beijing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy